Countdown to Submit Your Abstract:

  • 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds

Thanks to all who have submitted an abstract by the May 23rd deadline. Abstract peer review is underway and notifications will be sent out mid June.

Continuing with this strong track record of success, the 10th International Conference on Tularemia will be held at the World Trade Center in Grenoble Alps, France, from 25-28 September, 2023. The conference will include a keynote address as well as six plenary sessions, poster previews (flash talks) and two poster sessions, with additional opportunities for networking during shared meals and social activities.

The program will be comprised of common plenary sessions and poster sessions, without any breakout or parallel sessions. Each plenary session will be chaired by and include invited speakers who are recognized leaders in the field. As a means to feature the most up-to-date and exciting unpublished science, most of the speakers will be selected based on the merits of submitted abstracts. This structure provides maximum presentation opportunities to trainees and early career investigators, and offers a supportive environment in which trainees and all attendees can build their knowledge, hone presentation skills and establish professional mentor/mentee relationships in the community.

The Tularemia International Society wishes to acknowledge our sponsors and their financial support making this meeting possible:

Funding for this conference is made possible, in part, by the Food and Drug Administration through grant 1 R13 FD007810-01. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does any mention of trade names, commercial practices, or organization imply endorsement by the United States Government. 

This award is subject to the programmatic Terms and Conditions as specified in the Funding Opportunity Announcement: PAR 19-306 entitled FDA Scientific Conference Grant Program (R13). 


Tularemia is a rapidly progressive and potentially fatal zoonosis of humans caused by the intracellular bacterial pathogen, Francisella tularensis. Because of its low infectious dose and lethality when inhaled, F. tularensis was developed as a bioweapon by three countries, and remains a potential bioterroist agent. Research and understanding of tularemia pathogenesis, diagnosis, treatment, and prevention have been significantly advanced by the International Conferences on Tularemia, the first of which was held in Umea, Sweden in 1995. Attendance and impact of this triennial series of meetings has grown steadily in subsequent years. At present, this conference is a unique venue that brings together scientists and interested parties from the U.S., Canada, Scandinavia, Europe, Russia, and Japan.

Apply for TULISOC Membership or Renew your Membership

TULISOC Membership

Regular Three-Year Membership

  • $75 Discount on Academic/Government Registration Fee for Tularemia 2023 in Grenoble, France

  • Membership is Valid through 31 December 2025

  • Inclusion & Access to the TULISOC Online Membership Directory for Networking

  • Vote and Hold Office in the Society

Regular Member

  • Membership is Valid through 31 December 2023

  • Inclusion & Access to the TULISOC Online Membership Directory for Networking

  • Vote and Hold Office in the Society

Student Member

Graduate/Undergraduate Student or Postdoc
  • Membership is Valid through 31 December 2023

  • Inclusion & Access to the TULISOC Online Membership Directory for Networking

  • Vote and Hold Office in the Society

Emeritus or Special Member

For those scientists who are retired or if financial or political conditions make it difficult to pay regular dues
  • Please contact the TULISOC to request Emeritus or Special Membership.

Any professional who is involved in research, teaching and/or public service and whose activities are related to the study of tularemia is eligible for membership provided that he/she supports the goals and objectives of the Society as set forth in the Terms of Reference and By-Laws.

Statistics from 9th International Conference on Tularemia, Montreal, Canada
Number of Participants
Number of Poster Presentations
Number of Oral Presentations

Latest News